SPH
SOPHARMA AD
GPW
LISTED
MARKET CAP
Market capitalization — shares outstanding times share price.
5.8 mld
as of October 04, 2026
FREE FLOAT
The portion of capital not covered by notifications above 5% of votes — its composition is not publicly known.
33.91%
ANNOUNCEMENTS / 30 DAYS
Number of current reports the company published in the last 30 days.
48
REPORTS IN DATABASE
Number of analyzed periodic reports on file for this company.
0
13:27
Oct 01
Inne
Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 30.09.2026
Spółka Sopharma AD otrzymała powiadomienie MAR od podmiotu Kaliman RT AD dotyczące transakcji na akcjach spółki przeprowadzonych 30 września 2026 roku.
→
10:29
Oct 01
Inne
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with warrants of "Sopharma" AD with ISIN BG9200001253 on 30.09.2026
Donev Investments Holding AD przekazał powiadomienie o transakcjach na warrantach spółki Sopharma AD przeprowadzonych w dniu 30.09.2026 r.
→
13:27
Sep 30
Inne
Notification from Alexandar Tchaoushev in accordance with Regulation 596/2014 for transactions on 29.09.2026 with shares of "Sopharma" AD
Alexandar Tchaoushev przekazał powiadomienie o transakcjach na akcjach Sopharma AD dokonanych w dniu 29 września 2026 roku.
→
10:27
Sep 29
Inne
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with warrants of "Sopharma" AD with ISIN BG9200001253 on 28.09.2026
Donev Investments Holding zgłosił transakcje z warrantami Sopharmy AD (ISIN BG9200001253) w dniu 28 września 2026 r. zgodnie z regulacją 596/2014.
→
09:32
Sep 29
Inne
Notification from "Kaliman RT" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD on 28.09.2026
Spółka **Kaliman RT AD** zgłosiła transakcję z akcjami Sopharmy AD z dnia **28.09.2026** zgodnie z regulacją 596/2014.
→
No analyzed reports for this company yet.
Analyses are produced from periodic reports — we have not processed one yet.
Company data Expand Collapse
- Website
- http://www.sopharmagroup.com
- mail@sopharma.bg
- Sector
- Produkcja Leków
- Industry
- Produkcja Leków
- Exchange
- GPW
- Country
- PL
- ISIN
- BG11SOSOBT18
- CEO
- Ognian Donev
- Address
- 16 IIIENSKO SHOSSE ST. 1220 SOPHIA
- Phone
- 00 35928134200
- Fax
- 00 35929360286
- Listed since
- November 01, 2011
- Shares outstanding
- 539,157,603
- Market cap
- 5.8 mld
- Status
- Active
We don't have a contract registry for this company yet.
The registry is built from significant-contract announcements — this company has published none.
We don't have a dividend payout history for this company yet.
Payout history is derived from dividend announcements — this company has declared none.
We haven't analyzed any reports for this company yet.
LARGEST STAKE
40.25%
Donev Investments Holding
FREE FLOAT
33.91%